DUARTE, Calif., March 18, 2025 /PRNewswire/ -- Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants ...

Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants, announced today that Erin Hamilton Spence, MD, IBCLC, ...

Dr. Melinda Elliott, a neonatologist and Chief Medical Officer at Prolacta Bioscience, joins us to discuss the importance of nutrition for premature infants.

We're discussing the importance of nutrition for premature infants with Prolacta Bioscience.

Progress for Premature Infants Spans From NICU Feeding Practices to Health Policy DUARTE, Calif., Nov. 12, 2024 /PRNewswire/ -- In recognition of Prematurity Awareness Month, Prolacta Bioscience ...

Prolacta Bioscience® is a global life sciences company dedicated to Advancing the Science of Human Milk® to improve health outcomes for critically ill and premature infants.

DUARTE, Calif., Oct. 1, 2024 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants ...

Prolacta Bioscience ®, the world's leading hospital provider of 100% human milk-based nutritional products, takes its obligation to the critically ill and premature infants it serves, and to the ...

DUARTE, Calif., July 24, 2024 /PRNewswire/ -- Prolacta Bioscience ®, the world's leading hospital provider of 100% human milk-based nutritional products, takes its obligation to the critically ...

Prolacta’s announcement also raised the possibility that the pharmaceutical development unit might eventually be spun off into a separate company, though no timetable was given.

Prolacta's 100% human milk-based nutritional products have been evaluated in more than 20 clinical studies published in peer-reviewed journals.